Resoconti Johnson & Johnson

Azioni

JNJ

US4781601046

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 26/04/2024			Variaz. 5gg	Var. 1 gen.
146,1 ^USD	-0,46%		-1,20%	-6,76%

26/04	Johnson & Johnson afferma che il CHMP europeo raccomanda l'approvazione di Rybrevant più chemioterapia per il trattamento del cancro al polmone	MT
25/04	JOHNSON & JOHNSON : rating Neutral da Redburn Atlantic	ZM

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Johnson & Johnson, Q1 2024 Earnings Call, Apr 16, 2024	16/04
Transcript : Johnson & Johnson, Shockwave Medical, Inc. - M&A Call	05/04
Transcript : Johnson & Johnson Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:45 AM	13/03
Transcript : Johnson & Johnson Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 01:00 PM	12/03
Transcript : Johnson & Johnson Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 11:10 AM	04/03
Transcript : Johnson & Johnson, Q4 2023 Earnings Call, Jan 23, 2024	23/01
Transcript : Johnson & Johnson Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM	08/01
Transcript : Johnson & Johnson - Special Call	05/12
Transcript : Johnson & Johnson, Q3 2023 Earnings Call, Oct 17, 2023	17/10/23
Transcript : Johnson & Johnson Presents at Climate Week, Sep-19-2023 11:00 AM	19/09/23
Transcript : Johnson & Johnson Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 10:10 AM	13/09/23
Transcript : Johnson & Johnson Presents at Wells Fargo Securities Healthcare Conference 2023, Sep-07-2023 10:15 AM	07/09/23
Transcript : Johnson & Johnson, 2023 Guidance/Update Call, Aug 30, 2023	30/08/23
Transcript : Johnson & Johnson Presents at UBS MedTech, Tools and Genomics Summit 2023, Aug-15-2023 11:00 AM	15/08/23
Transcript : Johnson & Johnson, Q2 2023 Earnings Call, Jul 20, 2023	20/07/23
Transcript : Johnson & Johnson Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 01:20 PM	13/06/23
Transcript : Johnson & Johnson Presents at Bernsteinâ€™s 39th Annual Strategic Decisions Conference 2023, May-31-2023 10:00 AM	31/05/23
Transcript : Johnson & Johnson, Q1 2023 Earnings Call, Apr 18, 2023	18/04/23
Transcript : Johnson & Johnson Presents at Barclays Global Healthcare Conference, Mar-14-2023 10:15 AM	14/03/23
Transcript : Johnson & Johnson Presents at Cowen 43rd Annual Healthcare Conference, Mar-07-2023 11:10 AM	07/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

La pipeline di farmaci è ben posizionata per il 2024, dice il CFO di J&J

23 gennaio 2024 alle 18:30